Annals of Internal Medicine

12/28/2025

Annals Video Summaries are systematic reviews condensed into short, easy-to-digest videos designed for busy clinicians like you. Discover this timesaving way to keep current—check out the selection of videos today! https://f.mtr.cool/dpuqijnhif

12/27/2025

ACP Journal Club helps you stay current with the latest evidence-based clinical information relevant to internal medicine and its subspecialties. Explore today:

ACP Journal Club summarizes the best new evidence for internal medicine from over 120 clinical journals. Research staff from McMaster University and clinical editors rigorously assess the scientific merit of the medical literature as it is published and a worldwide panel of over 3600 physicians asse...

12/26/2025

Recent RA trials have predominantly focused on quantification of weight loss, adverse effects, and clinical outcomes, whereas physical functioning outcomes remain largely unexamined. A commentary emphasizes the importance of including physical function outcome measures in GLP-1RA trials focusing on . https://bit.ly/4s4Ar1X

12/26/2025

In an editorial, Ziva D. Cooper, PhD from the UCLA Center for Cannabis and Cannabinoids calls for new approaches that leverage observational data to provide insight into the role of in the treatment of chronic pain. https://bit.ly/3MHwccG

12/25/2025

Happy holidays from everyone at Annals of Internal Medicine!

12/24/2025

The strength of Annals of Internal Medicine depends largely on the ability and effort of many hundreds of reviewers. We offer our gratitude and thanks to all reviewers! Find a full list here: https://bit.ly/4q1tAVu

12/24/2025

In a new commentary, Annals of Internal Medicine Associate Editor Michael Bretthauer, MD, PhD reflects on his experience leading a large clinical trial with results that challenged prior beliefs and underscores the importance of unbiased trial conduct. https://bit.ly/494n2yf

12/23/2025

NEW: A phase 2 study from Gilead Sciences and Merck finds that once-weekly oral islatravir plus lenacapavir (ISL+LEN) maintained high rates of virologic suppression at 48 weeks in people with HIV-1 with no serious adverse events. These results suggest that ISL+LEN may offer a promising once-weekly treatment regimen that could help address adherence challenges in HIV care. https://bit.ly/4p6X5Ek

12/23/2025

An Annals from Peter Sherman depicts the frustrations physicians experience with online medical advice. https://bit.ly/491oNw5

12/23/2025

A new review found that high-THC products may offer modest short-term relief for , while CBD-only products show no clear benefit. However, side effects like dizziness and nausea were common. Read the review here: https://bit.ly/4b4dfL7

12/22/2025

Annals for Educators provides practical teaching points for recently published articles. In the latest issue, explore trends in cancer incidence among older and younger adults, the for IBS, and much more. https://bit.ly/494dZNE

12/20/2025

Annals of Internal Medicine and Annals of Internal Medicine: Clinical Cases () offer convenient ways to fulfill both your CME and MOC credit requirements:

Annals of Internal Medicine and Annals of Internal Medicine: Clinical Cases offer convenient ways to fulfill both your CME and MOC requirements. After logging in, it takes just a few minutes to earn credit using one of two models: complete the short quiz that accompanies articles with the "CME/MOC"....